Furosemide: Clinical Trials

11 trials of Furosemide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 terminated. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Terminated 11

Follow Furosemide: new trials by email Literature Review of Furosemide trials Research Report on Furosemide

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance
Furosemide, Metolazone, Acetazolamide - Acute Heart Failure, Diuretic Resistance
Phase 4TerminatedStadtspital Zürich132023-10-102025-02-14
Diuretic Use in Hemodialysis Patients With Residual Renal Function
Furosemide, Chlorthalidone - End Stage Renal Disease on Dialysis
Phase 4TerminatedUniversity of Alberta22023-05-292026-05-08
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis
ORKID Bundled Intervention, Furosemide - Acute Kidney Injury, Dialysis Hypotension
Phase 4TerminatedUniversity of California, San Francisco12021-10-182023-05-12
Postpartum Management of Gestational Hypertensive Disorders Using Furosemide
furosemide, labetalol - Hypertension, Pregnancy-Induced
Phase 4TerminatedWright State University132020-05-012023-10-23
Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients
Furosemide Injection, Albumin Human - Cirrhosis, Liver, Volume Overload
Phase 4TerminatedRush University Medical Center212019-12-192025-09-16
FURosemide Stress Test to Predict Need of Renal Replacement THERapy in Ischemic Acute Tubular Necrosis in ICU
Furosemide - Acute Kidney Injury
Phase 4TerminatedAssistance Publique - Hôpitaux de Paris112019-07-152020-12-16
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
Metolazone 60 minutes prior to furosemide, Metolazone concurrently with furosemide - Fluid Overload, Heart Failure Acute
Phase 4TerminatedUniversity of Maryland, Baltimore32019-01-012021-10-22
Forced Fluid Removal in High Risk Acute Kidney Injury
Furosemide (Furix), Continuous renal replacement therapy (CRRT), Resuscitation - Acute Kidney Injury, Fluid Overload
Phase 4TerminatedNordsjaellands Hospital212015-10-012017-07-06
REWORD-HF REverse WOrsening Renal Function in Decompensated Heart Failure
Furosemide or Furosemide and Dopamine, Ultrafiltration - Acute Decompensated Heart Failure
Phase 4TerminatedNiguarda Hospital102011-02-012017-04-10
Dopamine in Acute Decompensated Heart Failure II
High-dose furosemide, Low-dose furosemide, Low-dose furosemide combined with low-dose dopamine - Acute Decompensated Heart Failure
Phase 4TerminatedLarissa University Hospital1612009-07-012013-09-11
Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure
Addition of oral Metolazone, Furosemide dose escalation - Acute Decompensated Heart Failure
Phase 4TerminatedUniversity of North Carolina, Chapel Hill112008-10-012018-03-13

Conditions studied

Acute Kidney Injury (3)  ·  Edema (3)  ·  Critical Illness (1)  ·  Heart Failure (1)  ·  Hypertension, Pregnancy-Induced (1)  ·  Hypokalemia (1)  ·  Liver Cirrhosis (1)  ·  Pre-Eclampsia (1)  ·  Sepsis (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Larissa University Hospital (1)  ·  Niguarda Hospital (1)  ·  Nordsjaellands Hospital (1)  ·  Rush University Medical Center (1)  ·  Stadtspital Zürich (1)  ·  University of Alberta (1)  ·  University of California, San Francisco (1)  ·  University of Maryland, Baltimore (1)  ·  University of North Carolina, Chapel Hill (1)  ·  Wright State University (1)

Countries

United States (6)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  Switzerland (1)

Top investigators

Anders Perner, Md, Ph D (1)  ·  Antonio Santoro, MD (1)  ·  Branko Braam, MD/Ph.D. (1)  ·  Brent Reed, PharmD (1)  ·  Chi-yuan Hsu, MD, MSc (1)  ·  Fabrizio Oliva, MD (1)  ·  Filippos Triposkiadis, MD (1)  ·  Gregory Giamouzis, MD (1)  ·  Ian McCoy, MD, MS (1)  ·  Jens-Ulrik Jensen, MD, Ph D (1)  ·  Jo E. Rodgers, PharmD (1)  ·  Lance Lance Lineberger, PharmD (1)  ·  Mattia Arrigo, PD, Dr. med. (1)  ·  Michael Ibsen, MD, Ph D (1)  ·  Morten H Bestle, MD, Ph D (1)

Results publications

PMID 24485633, PMID 28438182, PMID 29664109, PMID 35061249

NIH funding

2015 (1)